Merck Life Sciences - Search News

Merck KGaA Earnings Growth Beats Expectations

Merck KGaA reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in the life-sciences segment, but said full-year sales would come in at the bottom end of the forecast range. Earnings before interest ...

Reuters · 22h

Merck KGaA Q3 earnings rise faster than expected on lower costs

Merck, which previously predicted 2024 sales between 20.7 ... compared with 5.9 billion reported for 2023. Its Life Science unit, which makes gear and supplies for biotech labs, continues to regain ground from a slump after the end of the COVID-19 pandemic ...

Seeking Alpha · 8h

Merck KGaA (MKGAF) Q3 2024 Earnings Call Transcript

Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor

ENDPOINTS NEWS12h

Merck KGaA’s life science unit is still feeling the Covid demand decline

Merck KGaA reported a 16.6% decline in contract manufacturing due to an unrepeated Covid-19 contract, though overall life ...

bnnbloomberg19h

Merck KGaA Beats Estimates on Boost From Life Science Unit

(Bloomberg) -- Merck KGaA posted earnings that topped estimates as its life science unit recovers from its ...

The Pharma Letter10h

Merck & Co wades into PD-1/VEGF space via deal with LaNova Medicines

Merck & Co has entered into an exclusive global license to develop, manufacture and commercialize LM-299 from China-based ...

14h

Merck KGaA stock falls on weak Q3, soft outlook

Investing.com -- Shares of Merck KGaA (ETR: MRCG) fell over 4% on Thursday following a mixed reception to its third-quarter ...

Business Wire3d

European Life Science Tools and Reagents Market Research 2023-2024 & 2029: Thermo Fisher Scientific, Danaher., Merck, Qiagen and Roche Lead the Industry - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "European Life Science Tools and Reagents Market" report has been added to ResearchAndMarkets.com's offering. The European market for life science tools and ...

The Pharma Letter11h

Merck KGaA shares slip on cautious outlook

Merck, which previously predicted 2024 sales of between ... data analyses and commentary from our global network of life ...

21h

Germany’s Merck Expects Sales at Lower End of Outlook Range After Third-Quarter Miss

The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results